Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis
Recovery setup
Healthcare · Medical Care Facilities
Sell if holding. Engine safety override at $7.72: Risk below floor (2.8 < 3.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.4/10. Specifically: Elevated put/call ratio: 5.50; Below long-term trend.
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost... Read more
Sell if holding. Engine safety override at $7.72: Risk below floor (2.8 < 3.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.4/10. Specifically: Elevated put/call ratio: 5.50; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 54. Score 6.4/10, moderate confidence.
Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-06-17Recent Developments — Aveanna Healthcare Holdings Inc
Latest news
- NEWS Aveanna (AVAH) Stock Analysis: +0.66% Gain — What to Watch 2026-05-20 - Bullish Percent Index - Newser — Newser positive
- NEWS Aveanna Healthcare: Q1 Results Confirm My Reasons For Optimism (NASDAQ:AVAH) - Seeking Alpha — Seeking Alpha positive
- NEWS Aveanna Healthcare Raises 2026 Guidance After Family First Acquisition - The Globe and Mail — The Globe and Mail positive
- NEWS Aveanna Healthcare shares dip despite Q4 earnings beat as 2026 outlook disappoints - MSN — MSN positive
- NEWS Aveanna stock gains after hiking outlook (AVAH:NASDAQ) - Seeking Alpha — Seeking Alpha positive
Generated 2026-06-17T09:02:25Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers·1 ceiling hit
Volatile — 5.3% daily ATR makes tight stops impractical. Position-size conservatively.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $7.72: Risk below floor (2.8 < 3.0) triggers a hard block regardless of the otherwise-positive setup — overall score 6.4/10. Specifically: Elevated put/call ratio: 5.50; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 54. Prior stop was $6.99. Score 6.4/10, moderate confidence.
Take-profit target: $8.74 (+16.2% upside). Prior stop was $6.99. Stop-loss: $6.99.
Risk below floor (2.8 < 3.0).
Aveanna Healthcare Holdings Inc trades at a P/E of 6.0 (forward 9.4). TrendMatrix value score: 8.8/10. Verdict: Sell.
17 analysts cover AVAH with a consensus score of 4.1/5. Average price target: $10.
What does Aveanna Healthcare Holdings Inc do?Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare...
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.